Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms (vol 45, pg 1524, 2017)

Coyle C.; Crawford G.; Wilkinson J.; Thomas S. J.; Bytzer P.

首页> 外文期刊>Alimentary pharmacology & therapeutics. >Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms (vol 45, pg 1524, 2017)

【24h】

Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms (vol 45, pg 1524, 2017)

机译：随机临床试验：向突破症状患者的藻酸盐 - 抗酸（Gaviscon双重作用）添加到质子泵抑制剂治疗（Vol 45，PG 1524,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Alimentary pharmacology & therapeutics.》 |2017年第10期|共1页
作者
Coyle C.; Crawford G.; Wilkinson J.; Thomas S. J.; Bytzer P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms (vol 45, pg 1524, 2017) [J] . Coyle C., Crawford G., Wilkinson J., Alimentary pharmacology & therapeutics. . 2017,第10期

机译：随机临床试验：向突破症状患者的藻酸盐 - 抗酸（Gaviscon双重作用）添加到质子泵抑制剂治疗（Vol 45，PG 1524,2017）
2. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor [J] . Reimer C., Lodrup A. B., Smith G., Alimentary pharmacology & therapeutics. . 2016,第8期

机译：随机临床试验：海藻酸钠（Gaviscon Advance）与安慰剂的比较，作为对每天一次质子泵抑制剂反应不足的反流患者的补充疗法
3. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor [J] . Reimer C., Lodrup A. B., Smith G., Alimentary pharmacology & therapeutics. . 2016,第8期

机译：随机临床试验：藻酸盐（Gaviscon Advance）与安慰剂作为回流患者的附加治疗患者对一次日常质子泵抑制剂的反应不足
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China [O] . J. Sun, C. Yang, H. Zhao, -1

机译：随机临床试验：海藻酸钠-抗酸药（Gaviscon Double Action）与安慰剂相比可减轻中国有症状胃食管反流病（GERD）的上消化道症状的临床疗效和安全性
6. Retraction: Randomised clinical trial: The clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China by J. Sun [O] . 2018

机译：撤回：随机临床试验：藻酸盐 - 抗酸（Gaviscon双作用）对安慰剂的临床疗效和安全性，用于通过J. Sun在中国的症状胃食管反流疾病（GERD）中的上胃肠道症状降低

Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms (vol 45, pg 1524, 2017)

著录项

相似文献

相关主题

期刊订阅